Pharmaceutical compound
Clinical data | |
---|---|
Other names | Kemantane; Kemantan; 5-Hydroxyadamantanone; 4-Oxo-1-adamantanol; 4-Oxoadamantan-1-ol; 1-Hydroxy-4-ketoadamantane |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C10H14O2 |
Molar mass | 166.220 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Idramantone, also known as kemantane or as 5-hydroxyadamantan-2-one, is an experimental immunostimulant of the adamantane group that was never marketed. It is described as a lymphocyte and antibody stimulant in mice and as a T-cell suppressor. The drug was first described by 1968.
References
- ^ Buckingham J, Macdonald F (1996). Dictionary of Organic Compounds (Sixth, Supplement 1 ed.). Taylor & Francis. p. 152. ISBN 978-0-412-54110-0. Retrieved 13 September 2024.
- ^ Morton IK, Hall JM (2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Netherlands. p. 145. ISBN 978-94-011-4439-1. Retrieved 13 September 2024.
This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it. |